insights_auto
Why is IMCR up ၃.၇၂%?
Dive Deeperchevron_right
IMCR:NASDAQ
Immunocore Holdings PLC - ADR
၂၉.၄၀ US$
arrow_upward
+၃.၇၂%(+၁.၀၆) 1D
အောက် ၁၅, GMT-၄ ၁၅:၂၃:၄၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IMCR...
Open
၂၈.၇၃ US$
High
၂၉.၉၀ US$
Low
၂၈.၇၃ US$
Mkt. cap
၁၅၃.၅၄ ဋေ
Avg. vol.
၄.၁၇ သိန်း
Volume
၁.၅၇ သိန်း
52-wk high
၄၀.၇၁ US$
52-wk low
၂၇.၅၀ US$
EPS
-၀.၃၇ US$
Beta
၀.၈၁
Shares outstanding
၅.၁၅ ကုဋေ
No. of employees
၅၂၄
Open
၂၈.၇၃ US$
High
၂၉.၉၀ US$
Low
၂၈.၇၃ US$
Mkt. cap
၁၅၃.၅၄ ဋေ
Avg. vol.
၄.၁၇ သိန်း
Volume
၁.၅၇ သိန်း
52-wk high
၄၀.၇၁ US$
52-wk low
၂၇.၅၀ US$
EPS
-၀.၃၇ US$
Beta
၀.၈၁
Shares outstanding
၅.၁၅ ကုဋေ
No. of employees
၅၂၄
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
Immunocore stock faces USD 56.38 target 91.97 percent above price
Stock Titan
·
ပြီးခဲ့သည့် ၈ နာရီ
Insulin-making cells are just 1% of the pancreas. Immunocore has dosed its first patient in a trial to protect them.
Profile
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology. Wikipedia
About Immunocore Holdings PLC - ADR